OpenBilldrug price receipt

NADAC week of 2026-10-14

EPINEPHRINE 0.15 MG AUTO-INJCT

For 1 unit (EA)

Pharmacies pay

$117.97 – $141.88 filed

1 × $117.96603 to $141.88177 per EA (the 6 NDCs differ)

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$99.63 filed

1 × $99.62948 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.70× – 0.84× estimated

Medicare paid between 0.70× and 0.84× what pharmacies pay, depending on the NDC.

Part D averages every strength and form sold under “Epinephrine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$140.67 – $168.16 estimated

NADAC for the pack + 15% + $5.00 fee per fill

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

EPINEPHRINE 0.15 MG AUTO-INJCT is how the CMS NADAC file names this product. The FDA NDC Directory lists it as epinephrine.

FDA gives its dosage form as injection and its route as “intramuscular; subcutaneous”, “subcutaneous” and “intramuscular”.

Its labelers, the companies named on the label, are Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals of New York LLC and Viatris Specialty LLC.

FDA lists it under 3 Established Pharmacologic Classes: alpha-Adrenergic Agonist, beta-Adrenergic Agonist and Catecholamine.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes); the FDA directory lists 4 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $117.97 – $141.88 for 1 unit (EA), depending on the NDC ($117.96603 to $141.88177 per EA), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 6 NDCs

Other strengths, forms and brands

8 other products in the NADAC file share the FDA nonproprietary name epinephrine with EPINEPHRINE 0.15 MG AUTO-INJCT.

ProductPharmacies pay per unitMedicare per unit
ADRENALIN 1 MG/ML VIAL
brand · injection
$7.79554 per ML filed
eff. 2025-10-28
$13.74495 per ML filed
Part D 2024 average
AUVI-Q 0.1 MG AUTO-INJECTOR
brand · injection, solution
$309.55227 per EA filed
eff. 2026-07-01
$300.57204 per EA filed
Part D 2024 average
AUVI-Q 0.15 MG AUTO-INJECTOR
brand · injection, solution
$309.85103 per EA filed
eff. 2026-07-01
$300.57204 per EA filed
Part D 2024 average
AUVI-Q 0.3 MG AUTO-INJECTOR
brand · injection, solution
$309.37573 per EA filed
eff. 2026-07-01
$300.57204 per EA filed
Part D 2024 average
EPINEPHRINE 0.15 MG AUTO-INJCT this page
generic · injection
$117.96603 to $141.88177 per EA filed
eff. 2026-09-23
$99.62948 per EA filed
Part D 2024 average
EPINEPHRINE 0.3 MG AUTO-INJECT
generic · injection
$111.99764 to $141.27567 per EA filed
eff. 2026-09-23
$99.62948 per EA filed
Part D 2024 average
EPINEPHRINE 1 MG/10 ML LUERJET
generic · injection
$1.23804 per ML filed
eff. 2026-09-23
We don’t know yet
NEFFY 1 MG/0.1 ML NASAL SPRAY
brand · spray
$360.13761 per EA filed
eff. 2026-09-23
$340.89238 per EA filed
Part D 2024 average
NEFFY 2 MG/0.1 ML NASAL SPRAY
brand · spray
$359.49229 per EA filed
eff. 2026-09-23
$340.89238 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-10-28, 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $129.05328 per EA filed.

Of the 59 other products in FDA’s alpha-Adrenergic Agonist class priced per EA, 6 have a higher middle NADAC price and 53 a lower one. The one in the middle is FEXOFENADINE-PSE ER 60-120 TAB, at $0.48321 per EA filed (eff. 2026-09-23).

Of the 6 other products in FDA’s beta-Adrenergic Agonist class priced per EA, 6 have a higher middle NADAC price and 0 a lower one. The one in the middle is AUVI-Q 0.1 MG AUTO-INJECTOR, at $309.55227 per EA filed (eff. 2026-07-01).

Of the 6 other products in FDA’s Catecholamine class priced per EA, 6 have a higher middle NADAC price and 0 a lower one. The one in the middle is AUVI-Q 0.1 MG AUTO-INJECTOR, at $309.55227 per EA filed (eff. 2026-07-01).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $99.63 for 1 unit (EA), at an average of $99.62948 per EA in 2024 (2024-01-01 to 2024-12-31) for “Epinephrine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 578,447 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for EPINEPHRINE 0.15 MG AUTO-INJCT labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Epinephrine / Epinephrine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. 12 of 13 NADAC NDCs joined to this name are priced per EA (1 per ML): CMS's average mixes those units.
Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists 4 of its 6 NDCs (it does not list the other 2) as dosage form “INJECTION” with routes “INTRAMUSCULAR”, “INTRAMUSCULAR; SUBCUTANEOUS”, “SUBCUTANEOUS”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.